Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results"

About the Authors: Axel C. Mühlbacher Roles Conceptualization, Methodology, Project administration, Writing – original draft, Writing – review & editing * E-mail: muehlbacher@hs-nb.de Affiliations Health Economics and Health Care Management, Hochschule Neubrandenburg, Neubrandenburg, Germany, Ge...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-02, Vol.16 (2), p.e0245480-e0245480
Main Authors: Mühlbacher, Axel C, Sadler, Andrew
Format: Article
Language:English
Subjects:
Analysis
Antiviral drugs
Decision analysis
Drug therapy
Economics
Editing
Efficiency
Engineering and Technology
Formal Comment
Genotypes
Health care
Health economics
Health risks
Hepatitis
Hepatitis C
Indicators
Medical care, Cost of
Medical ethics
Medicine and health sciences
Multiple criterion
Performance measurement
Preferences
Research and Analysis Methods
Science Policy
Social Sciences
Uncertainty analysis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:About the Authors: Axel C. Mühlbacher Roles Conceptualization, Methodology, Project administration, Writing – original draft, Writing – review & editing * E-mail: muehlbacher@hs-nb.de Affiliations Health Economics and Health Care Management, Hochschule Neubrandenburg, Neubrandenburg, Germany, Gesellschaft für Empirische Beratung GmbH (GEB), Freiburg, Germany ORCID logo https://orcid.org/0000-0003-4402-9211 Andrew Sadler Roles Writing – review & editing Affiliation: Health Economics and Health Care Management, Hochschule Neubrandenburg, Neubrandenburg, Germany Introduction The author of the paper to be discussed claims to have reanalyzed a case study on the efficiency frontier (EF). [...]there are several rather significant differences in the methodological approaches which are described and presented in detail in the papers [2, 3]. [...]we acknowledge that our reporting on the methods used for identification of included studies was incomplete (due to the limited number of studies available at the time of publication). In accordance to the Multi-Criteria Decision Analysis (MCDA) literature we applied and described the following steps in our VAF [9]: 1. definition of the decision problem to identify alternatives and decision tasks; 2. identification of relevant indicators and specification of the decision model; 3. performance measurement of each indicator; 4. scoring of indicators (normalization); 5. weighting of normalized indicators; 6. aggregation of indicators; 7. interpretation and analysis of uncertainty.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0245480